Supplementary_Tables_1_and_2_042819 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts

Supplemental material, Supplementary_Tables_1_and_2_042819 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology